IndraLab

Statements

Disulfiram inhibits NFKB1. 2 / 2
1 | 1
ctd
No evidence text available
10661865
reach
"In preclinical studies, disulfiram, when combined with copper ions, has been shown to act as a proteasome inhibitor, to induce oxidative stress, reduce NFkB activity, and enhance the sensitivity of cancer cells to chemotherapeutic drugs [XREF_BIBR]."
25593981